Terms: = Bone cancer AND NCOA2, TIF2, 10499, ENSG00000140396, NCoA-2, MGC138808 AND Diagnosis
18 results:
1. Small cell osteosarcoma versus fusion-driven round cell sarcomas of bone: retrospective clinical, radiological, pathological, and (epi)genetic comparison with clinical implications.
Hiemcke-Jiwa LS; Sumathi VP; Baumhoer D; Smetsers SE; Haveman LM; van Noesel MM; van Langevelde K; Cleven AHG; van de Sande MAJ; Ter Horst SAJ; Kester LA; Flucke U
Virchows Arch; 2024 Mar; 484(3):451-463. PubMed ID: 38332052
[TBL] [Abstract] [Full Text] [Related]
2. Detection of mesenchymal chondrosarcoma in pleural effusion with immunocytochemistry and determination of HEY1::ncoa2 fusion by next-generation sequencing on cell block.
Zhong J; Wang Q; Xie Y; Niu Z; Zhou D
Cytopathology; 2024 Jan; 35(1):149-152. PubMed ID: 37688410
[TBL] [Abstract] [Full Text] [Related]
3. NKX3.1 immunohistochemistry and methylome profiling in mesenchymal chondrosarcoma: additional diagnostic value for a well-defined disease?
Glauser S; Ameline B; Andrei V; Harder D; Pauli C; Trautmann M; Hartmann W; Baumhoer D
Pathology; 2023 Aug; 55(5):621-628. PubMed ID: 37225644
[TBL] [Abstract] [Full Text] [Related]
4. Clinicopathological and Molecular Characteristics of Intraosseous Rhabdomyosarcoma Involving Head and Neck Region: A Systematic Review and Meta-Analysis.
Sivakumar N; Sharma P; Chandra S; Gupta S; Samadi FM; Baghel S
Pediatr Dev Pathol; 2023; 26(3):299-309. PubMed ID: 37082926
[TBL] [Abstract] [Full Text] [Related]
5. Angiofibroma of soft tissue: Current status of pathology and genetics.
Nakayama S; Nishio J; Aoki M; Koga K; Nabeshima K; Yamamoto T
Histol Histopathol; 2022 Aug; 37(8):717-722. PubMed ID: 35211945
[TBL] [Abstract] [Full Text] [Related]
6. [Mesenchymal chondrosarcoma in central nervous system: a clinicopathological analysis].
Huang Q; Chen YP; Song FL; Zheng LM; Liu XY; Zhang S; Wang XF
Zhonghua Bing Li Xue Za Zhi; 2021 Aug; 50(8):870-875. PubMed ID: 34344069
[No Abstract] [Full Text] [Related]
7. NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population.
Ramanayake N; Vargas AC; Talbot J; Bonar F; Wong DD; Wong D; Mahar A; Karim R; Luk PP; Selinger C; Sioson L; Gill AJ; Maclean F
Pathology; 2021 Oct; 53(6):705-712. PubMed ID: 33640159
[TBL] [Abstract] [Full Text] [Related]
8. Diagnostic Utility of a Custom 34-Gene Anchored Multiplex PCR-Based Next-Generation Sequencing Fusion Panel for the diagnosis of bone and Soft Tissue Neoplasms With Identification of Novel USP6 Fusion Partners in Aneurysmal bone Cysts.
Dermawan JK; Cheng YW; Tu ZJ; Meyer A; Habeeb O; Zou Y; Goldblum JR; Billings SD; Kilpatrick SE; Reith JD; Shurtleff SA; Farkas DH; Rubin BP; Azzato EM
Arch Pathol Lab Med; 2021 Jul; 145(7):851-863. PubMed ID: 33147323
[TBL] [Abstract] [Full Text] [Related]
9. NKX3.1 immunoreactivity is not identified in mesenchymal chondrosarcoma: a 25-case cohort study.
Chen W; Hornick JL; Fletcher CDM
Histopathology; 2021 Jan; 78(2):334-337. PubMed ID: 32779239
[TBL] [Abstract] [Full Text] [Related]
10. OLIG2 Immunolabeling of Mesenchymal Chondrosarcoma: Report of 14 Cases.
Yao K; Duan Z; Yang S; Du Z; Wang Y; Qi X
J Neuropathol Exp Neurol; 2020 Sep; 79(9):959-965. PubMed ID: 32770197
[TBL] [Abstract] [Full Text] [Related]
11. [Cartilage tumors: morphology, genetics, and current aspects of target therapy].
Roessner A; Smolle M; Schoeder V; Haybaeck J
Pathologe; 2020 Mar; 41(2):143-152. PubMed ID: 32060685
[TBL] [Abstract] [Full Text] [Related]
12. An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing.
Baumhoer D; Amary F; Flanagan AM
Genes Chromosomes Cancer; 2019 Feb; 58(2):88-99. PubMed ID: 30582658
[TBL] [Abstract] [Full Text] [Related]
13. Minute mesenchymal chondrosarcoma within osteochondroma: an unexpected diagnosis confirmed by HEY1-ncoa2 fusion.
Toki S; Motoi T; Miyake M; Kobayashi E; Kawai A; Yoshida A
Hum Pathol; 2018 Nov; 81():255-260. PubMed ID: 29596896
[TBL] [Abstract] [Full Text] [Related]
14. Integrating Morphology and Genetics in the diagnosis of Cartilage Tumors.
de Andrea CE; San-Julian M; Bovée JVMG
Surg Pathol Clin; 2017 Sep; 10(3):537-552. PubMed ID: 28797501
[TBL] [Abstract] [Full Text] [Related]
15. Pancreatic involvement by mesenchymal chondrosarcoma harboring the HEY1-ncoa2 gene fusion.
Cohen JN; Solomon DA; Horvai AE; Kakar S
Hum Pathol; 2016 Dec; 58():35-40. PubMed ID: 27544802
[TBL] [Abstract] [Full Text] [Related]
16. Detection of HEY1-ncoa2 fusion by fluorescence in-situ hybridization in formalin-fixed paraffin-embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcoma.
Nakayama R; Miura Y; Ogino J; Susa M; Watanabe I; Horiuchi K; Anazawa U; Toyama Y; Morioka H; Mukai M; Hasegawa T
Pathol Int; 2012 Dec; 62(12):823-6. PubMed ID: 23252872
[TBL] [Abstract] [Full Text] [Related]
17. Identification of a novel, recurrent HEY1-ncoa2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data.
Wang L; Motoi T; Khanin R; Olshen A; Mertens F; Bridge J; Dal Cin P; Antonescu CR; Singer S; Hameed M; Bovee JV; Hogendoorn PC; Socci N; Ladanyi M
Genes Chromosomes Cancer; 2012 Feb; 51(2):127-39. PubMed ID: 22034177
[TBL] [Abstract] [Full Text] [Related]
18. Rearrangement of the MOZ gene in pediatric therapy-related myelodysplastic syndrome with a novel chromosomal translocation t(2;8)(p23;p11).
Imamura T; Kakazu N; Hibi S; Morimoto A; Fukushima Y; Ijuin I; Hada S; Kitabayashi I; Abe T; Imashuku S
Genes Chromosomes Cancer; 2003 Apr; 36(4):413-9. PubMed ID: 12619166
[TBL] [Abstract] [Full Text] [Related]
